DNLI
Price
$17.18
Change
+$0.37 (+2.20%)
Updated
May 3, 2:14 PM EST
95 days until earnings call
JANX
Price
$64.78
Change
+$2.35 (+3.76%)
Updated
May 3, 6:59 PM EST
4 days until earnings call
Ad is loading...

Compare trend and price DNLI vs JANX

Header iconDNLI vs JANX Comparison
Open Charts DNLI vs JANXBanner chart's image
Denali Therapeutics
Price$17.18
Change+$0.37 (+2.20%)
Volume$200
CapitalizationN/A
Janux Therapeutics
Price$64.78
Change+$2.35 (+3.76%)
Volume$559.98K
CapitalizationN/A
View a ticker or compare two or three
DNLI vs JANX Comparison Chart

Loading...

DNLIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
JANXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
DNLI vs. JANX commentary
May 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Buy and JANX is a Hold.

COMPARISON
Comparison
May 04, 2024
Stock price -- (DNLI: $16.81 vs. JANX: $62.43)
Brand notoriety: DNLI and JANX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 68% vs. JANX: 89%
Market capitalization -- DNLI: $2.39B vs. JANX: $3.24B
DNLI [@Biotechnology] is valued at $2.39B. JANX’s [@Biotechnology] market capitalization is $3.24B. The market cap for tickers in the [@Biotechnology] industry ranges from $559.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.61B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileJANX’s FA Score has 0 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • JANX’s FA Score: 0 green, 5 red.
According to our system of comparison, JANX is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 6 TA indicator(s) are bullish while JANX’s TA Score has 3 bullish TA indicator(s).

  • DNLI’s TA Score: 6 bullish, 4 bearish.
  • JANX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, DNLI is a better buy in the short-term than JANX.

Price Growth

DNLI (@Biotechnology) experienced а +12.37% price change this week, while JANX (@Biotechnology) price change was +32.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.27%. For the same industry, the average monthly price growth was -0.50%, and the average quarterly price growth was +1243.13%.

Reported Earning Dates

DNLI is expected to report earnings on Aug 06, 2024.

JANX is expected to report earnings on Aug 06, 2024.

Industries' Descriptions

@Biotechnology (+5.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for DNLI with price predictions.
OPEN
A.I.dvisor published
a Summary for JANX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
JANX($3.24B) has a higher market cap than DNLI($2.39B). JANX YTD gains are higher at: 481.827 vs. DNLI (-21.668).
DNLIJANXDNLI / JANX
Capitalization2.39B3.24B74%
EBITDAN/AN/A-
Gain YTD-21.668481.827-4%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
90
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLIJANX
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
86%
Declines
ODDS (%)
Bearish Trend 9 days ago
80%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
DNLIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
JANXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BGCSX14.650.28
+1.95%
Baillie Gifford EAFE Plus All Cap I
NOSGX19.290.24
+1.26%
Northern Small Cap Value
FLOWX17.100.18
+1.06%
Fidelity Water Sustainability
IYCEX16.270.16
+0.99%
Delaware Ivy Core Equity Fund Class R
FWMIX59.650.24
+0.40%
American Funds Washington Mutual F3

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been closely correlated with BEAM. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if DNLI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
+4.02%
BEAM - DNLI
69%
Closely correlated
+4.51%
NTLA - DNLI
66%
Loosely correlated
+3.42%
JANX - DNLI
59%
Loosely correlated
+7.29%
ALLO - DNLI
51%
Loosely correlated
+1.71%
XNCR - DNLI
51%
Loosely correlated
-1.25%
More

JANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, JANX has been loosely correlated with VKTX. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if JANX jumps, then VKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JANX
1D Price
Change %
JANX100%
+7.29%
VKTX - JANX
65%
Loosely correlated
-0.88%
DNLI - JANX
59%
Loosely correlated
+4.02%
LGND - JANX
54%
Loosely correlated
+1.26%
BEAM - JANX
47%
Loosely correlated
+4.51%
CDXS - JANX
41%
Loosely correlated
+7.40%
More